Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 9, 2010, Pages 1327-1332

  Lombardo, Lucio ^a   Leto, Rosalia ^a   Molinaro, Giancarlo ^a   Migliardi, Marco ^a   Ravarino, Nicoletta ^a   Rocca, Rodolfo ^a   Torchio, Bruno ^a  

^a MAURIZIANO HOSPITAL   (Italy)

Author keywords

atrophic gastritis; dyspepsia; gastrin 17; Gastro Panel; helicobacter pylori; pepsinogen I; pepsinogen II

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DYSPEPSIA; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROSCOPY; HEALTH SURVEY; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; STOMACH BIOPSY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DATA COLLECTION; DYSPEPSIA; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; GASTRITIS, ATROPHIC; GASTROINTESTINAL TRACT; HELICOBACTER PYLORI; HUMANS; ITALY; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; YOUNG ADULT;

HELICOBACTER PYLORI;

EID: 77957306893     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.256     Document Type: Article

References (45)

1. Cheli R, Giacosa A, Pirasso A. Chronic gastritis: a dynamic process toward cancer. In: Ming SC, editor. Precursor of gastric cancer. New York, USA: Praeger Scientific, 1984:117-29.
2. Correa P. A new paradigm for human carcinogenesis. J Clin Gastroenterol 2000;30:341-2.
3. Correa P. Chronic gastritis as a cancer precursor. Scand J Gastroenterol 1984;104:131-6. (Pubitemid 15191690)
4. Sipponen P. Gastric cancer-a long-term consequence of Helicobacter pylori infection? Scand J Gastroenterol 1994;29(suppl 201):24-7. (Pubitemid 24165470)
5. Genta RM. Gastric atrophy and atrophic gastritis-nebulous concepts in search of a definition. Aliment Pharmacol Ther 1998;12:17-23. (Pubitemid 28062488)
6. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global burden of disease study. Lancet 1997;349:1269-76.
7. De Vries AC, Kuipers EJ. Review article: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 2007;26:25-35. (Pubitemid 350233320)
8. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sidney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
9. Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008;40:650-8.
10. Mc Coll KE, Murray LS, Gillen D, Walker A, Wirz A, Fletcher J, et al. Randomized trial of endoscopic with testing for Helicobacter pylori compared with non-invasive H. pylori testing alone in the management of dyspepsia. Br Med J 2002;324:999-1002. (Pubitemid 34457507)
11. Della Monica P, Lavagna A, Masoero G, Lombardo L, Crocellà L, Pera A. Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy. Aliment Pharmacol Ther 2002;16:1269-75.
12. Masoero G, Lombardo L, Della Monica P, Vicari S, Crocellà L, Duglio A, et al. Discrepancy between Helicobacter pylori stool antigen assay and urea breath test in the detection of Helicobacter pylori infection. Dig Liv Dis 2000;32:285-90. (Pubitemid 30445065)
13. Plebani M, Basso D. Diagnosis of Helicobacter pylori by HpSA test. Lancet 1999;354:209-11.
14. Vaira D, Malfertheiner P, Megraud F, Axon AT. Diagnosis of Helicobacter pylori infection with a new non-invasive antigen based assay. Lancet 1999;354:30-3. (Pubitemid 29304299)
15. Dinis-Ribeiro M, Yamaki G, Miki K, Costa-Pereira A, Matsukawa M, Kurihara M. Meta-analysis of the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 2004;11:141-7. (Pubitemid 39274096)
16. Bodger KI, Wyatt JI, Heatley R. Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy. Helicobacter 2001;6:216-24. (Pubitemid 32843605)
17. Hartleb M, Wandzel P, Waluga M, Matiyszczyk B, Boldys H, Romanczyk T. Non-endoscopic diagnosis of multifocal atrophic gastritis. Efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies. Acta Gastroenterol Belg 2004;67:320-6. (Pubitemid 40188052)
18. Urita Y, Hike K, Torii N, Kikuchi Y, Kanda E, Sasajima M, et al. Serum pepsinogens predictor of the topography of intestinal metaplasia in patients with atrophic gastritis. Dig Dis Sci 2004;49:795-801. (Pubitemid 38870206)
19. Vaananen H, Vauhkonen M, Helske T, Kaariainen I, Rausmussen M, Tunturi-Hihnala H, et al. Non-endoscopic diagnosis of atrophic gastritis. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003;15:885-91. (Pubitemid 36904458)
20. McColl KE, el-Omar EM, Gillen D. Alterations in gastric physiology in Helicobacter pylori infection: causes of different diseases or all epiphenomena? Ital J Gastroenterol Hepatol 1997;29:459-64. (Pubitemid 28065787)
21. Broutet N, Plebani M, Sakarovitch C, Sièpponen P, Mégraud F. Pepsinogen A, pepsinogen C and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer 2003;88:1239-47. (Pubitemid 36606340)
22. Suzuki H, Masaoka T, Hosoda H, Nomura S, Ohara T, Kangawa K, et al. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio-a possible novel and non-invasive marker for gastric atrophy. Hepatogastroenterology 2004;51:1249-54. (Pubitemid 38987454)
23. Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol 2002;37:785-91. (Pubitemid 34836814)
24. Germanà B, Di Mario F, Cavallaro LG, Moussa AM, Lecis P, Liatoupolou S, et al. Clinical usefulness of serum pepsinogen I and II, gastrin-17 and Helicobacter pylori antibodies in the management of dyspeptic patients primary care. Dig Liv Dis 2005;37:501-8. (Pubitemid 44356059)
25. Derakhshan MH, El-Omar E, Oien K, Gillen D, Fyfe V, Crabtree JE, et al. Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori. J Clin Pathol 2006;59:1293-9. (Pubitemid 46048335)
26. Valle Munoz J, Artaza Varasa T, Lopez Pardo R, Rodriguez Merlo R, Perez Grueso MJ, Martin Escobedo R, et al. Serological diagnosis of atrophic gastritis with a combination of pepsinogen I and II, gastrin-17 and anti-Helicobacter pylori antibodies. Gastroenterol Hepatol 2007;30:567-71.
27. Reshetnikov OV, Kurilovich SA, Bobak M, Maliutina SK, Pylenkova ED. Gastrointestinal symptoms in adult population of Novosibirsk city: prevalence and risk factors. Ter Arkh 2009;81:11-6.
28. De Angelis GL, Cavallaro LG, Maffini V, Moussa AM, Fornaroli F, Liatopoulou S, et al. Usefulness of a serological panel test in the assessment of gastritis in symptomatic children. Di Dis 2007;25:206-13. (Pubitemid 350194169)
29. Di Mario F, Moussa AM, Caruana P, Merli R, Cavallaro LG, Cavestro GM, et al. "Serological biopsy" in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection. Scand J Gastroenterol 2003;38:1223-7. (Pubitemid 38096079)
30. Talley NJ, Stanghellini V, Heading R, Kock K, Malagelada J, Tytgat G. Functional gastroduodenal disorders. Gut 1999;45:1137-42. (Pubitemid 29434811)
31. Di Mario F, Cavallaro LG, Moussa AM, Caruana P, Merli R, Maini A, et al. Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity and density of the bacterium. Dig Dis Sci 2006;51:1791-5. (Pubitemid 44546748)
32. Micki K. Gastric cancer using the serum pepsinogen test method. Gastric Cancer 2006;9:245-53.
33. Westerveld BD, Pals G, Lamers CB, Defize J, Pronk JC, Frants RR. Clinical significance of pepsinogen A and C levels and serum gastrin levels. Cancer 1987;59:952-8.
34. Kekki M, Samloff IM, Varis K, Ihamàki T. Serum pepsinogen I and serum gastrin in screening of severe atrophic corpus gastritis. Scand J Gastroenterol 1991;186:109-16.
35. Sipponen P, Valle J, Varis K, Samloff IM, Huttunen J, Taylor PR, et al. Fasting levels of serum gastrin in different functional and morphological states of the antro-fundal mucosa. An analysis of 860 subjects. Scand J Gastroenterol 1990;25:513-9. (Pubitemid 20208216)
36. Varis K, Sipponen P, Laxén F, et al. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Scand J Gastroenterol 1998;33:294-300.
37. Palli D, Galli M, Caporaso Neil E, Cipriani F, Decarli A, Saieva C, et al. Family history and risk of stomach cancer in Italy. Cancer Epidem Biomar Prev 1994;3:15-8. (Pubitemid 24172516)
38. Di Mario F, Moussa AM, Dal Bò N, Caruana P, Pilotto A, Cavallaio LG, et al. Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: prospective 4-year study. J Gastroenterol Hepatol 2005;20:1661-6. (Pubitemid 43961069)
39. 13C urea breath test : variazioni della domanda dell-'esame nel corso degli ultimi 13 anni in un laboratorio di riferimento terziario. Sue possibili spiegazioni e implicanze. Degree thesis in Biomedic Laboratory Techniques. University of Turin, 2008.
40. st century: appropriate use of an invasive procedure in the era of non-invasive testing. Dig Liv Dis 2008;40:497-503.
41. Kuipers EJ. In through the out door: serology for atrophic gastritis. Eur J Gastroenterol Hepatol 2003;15:877-9.
42. Chun Yu Wong B, Lam SK, Wong W-M, Zheng W-M, Chen J, Chen B, et al. Eradicating Helicobacter pylori infection in general population prevents gastric cancer: a 7-year prospective randomized placebo-controlled study. Gastroenterology 2002;122(suppl 1): A588.
43. Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling costeffectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996;348:150-4. (Pubitemid 26238097)
44. Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 2007;42:2-10. (Pubitemid 46033039)
45. Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study. Scand J Gastroenterol 2008;43:1448-55.